This is filed on the steerable guide catheter to report the right access site bleeding and drop in hemoglobin level.It was reported that this was a mitraclip procedure to treat grade 4 mixed etiology mitral regurgitation (mr).The steerable guide catheter was inserted through the right groin access site.One mitraclip was implanted on (b)(6) 2018 reducing mr grade to 1.Post procedure, the patient had prolonged bleeding at the right access site.Manual compression and a temporary femstop device was applied.The bleeding resolved, but there was a drop in the hemoglobin level going from 10.6 down to 9.2.No further treatment was required.No additional information was provided.
|
(b)(4).The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the information reviewed, a conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.The reported patient effect of hemorrhage is listed in the mitraclip system instructions for use, as a known possible complication associated with mitraclip procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|